Sirt1 Links Ciita Deacetylation to Mhc Ii Activation

Xiaoyan Wu,Xiaocen Kong,Dewei Chen,He Li,Yuhao Zhao,Minjie Xia,Mingming Fang,Ping Li,Fei Fang,Lina Sun,Wenfang Tian,Huihui Xu,Yuyu Yang,Xiaohong Qi,Yuqi Gao,Jiahao Sha,Qi Chen,Yong Xu

DOI: https://doi.org/10.1093/nar/gkr651

IF: 14.9

2011-01-01

Nucleic Acids Research

Abstract:Antigen-dependent stimulation of T cells plays a critical role in adaptive immunity and host defense. Activation of major histocompatibility complex II (MHC II) molecules, dictated by Class II transactivator (CIITA), is considered a pivotal step in this process. The mechanism underlying differential regulation of CIITA activity by the post-translational modification machinery (PTM) and its implications are not clearly appreciated. Here, we report that SIRT1, a type III deacetylase, interacts with and deacetylates CIITA. SIRT1 activation augments MHC II transcription by shielding CIITA from proteasomal degradation and promoting nuclear accumulation and target binding of CIITA. In contrast, depletion of SIRT1 upregulates CIITA acetylation and attenuates its activity. Nicotinamide phosphoribosyltransferase (NAMPT) that synthesizes NAD(+) required for SIRT1 activation exerts similar effects on CIITA activity. Two different types of stress stimuli, hypobaric hypoxia and oxidized low-density lipoprotein (oxLDL), induce the acetylation of CIITA and suppress its activity by inhibiting the SIRT1 expression and activity. Thus, our data link SIRT1-mediated deacetylation of CIITA to MHC II transactivation in macrophages and highlight a novel strategy stress cues may employ to manipulate host adaptive immune system.